Effects of n-tritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model.
The modifying effects of the naturally occurring antioxidants n-tritriacontane-16,18-dione (TTAD), curcumin, dihydroguaiaretic acid (DHGA), chlorophyllin, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model were examined in male F344 rats. Animals were initiated with two i.p. injections of 2,2'-dihydroxy-di-n-propylnitrosamine (DHPN), followed by two i.g. administrations of N-ethyl-N-hydroxyethylnitrosamine (EHEN), and then three s.c. injections of 3,2'-methyl-4-aminobiphenyl (DMAB) during the first 3 weeks. Starting 1 day before the first carcinogen application, groups of rats received diet containing one of the antioxidants (0.2% TTAD, the others at 1% each) until 1 week after the last carcinogen exposure. Surviving animals were killed and complete autopsies were performed at the end of week 36. Histological examination revealed no inhibitory effects in terms of the multiplicities and/or incidences of neoplastic lesions in any of the organs examined, other than a significant increase in seminal vesicle atypical hyperplasia observed in rats treated with tannic acid. Thus, the antioxidants, with the exception of tannic acid, did not show any modifying effects on the initiation stage in the present multi-organ carcinogenesis model and at the present dose levels applied.
Takaba
K
K
First Department of Pathology, Nagoya City University, Medical School, Mizuho-cho, Mizuho-ku, Japan.
Hirose
M
M
Yoshida
Y
Y
Kimura
J
J
Ito
N
N
Shirai
T
T
D000611:Aminobiphenyl Compounds; D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D002273:Carcinogens; D002735:Chlorophyllides / Q000494:pharmacology; D003474:Curcumin / Q000494:pharmacology; D004052:Diethylnitrosamine / Q000031:analogs & derivatives; D006139:Guaiacol / Q000031:analogs & derivatives / Q000494:pharmacology; D047348:Hydrolyzable Tannins / Q000494:pharmacology; D017705:Lignans / Q000494:pharmacology; D008113:Liver Neoplasms / Q000517:prevention & control; D008175:Lung Neoplasms / Q000517:prevention & control; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009602:Nitrosamines; D010232:Paraffin / Q000494:pharmacology; D010833:Phytic Acid / Q000494:pharmacology; D011230:Precancerous Conditions / Q000517:prevention & control*; D051381:Rats; D011916:Rats, Inbred F344
D000611:Aminobiphenyl Compounds; D016587:Antimutagenic Agents; D000970:Antineoplastic Agents; D000975:Antioxidants; D002273:Carcinogens; D002735:Chlorophyllides; D047348:Hydrolyzable Tannins; D017705:Lignans; D009602:Nitrosamines; C023845:N-ethyl-N-hydroxyethylnitrosamine; C001042:2',3-dimethyl-4-aminobiphenyl; C071369:n-tritriacontane-16,18-dione; C015816:dihydroguaiaretic acid; D004052:Diethylnitrosamine; C012457:diisopropanolnitrosamine; D006139:Guaiacol; D010833:Phytic Acid; D010232:Paraffin; C007020:chlorophyllin; D003474:Curcumin